Outlook Therapeutics
OTLK
OTLK
16 hedge funds and large institutions have $5.79M invested in Outlook Therapeutics in 2017 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
64% less capital invested
Capital invested by funds: $16M → $5.79M (-$10.2M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
16
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$128K | |
| 2 | +$65K | |
| 3 | +$32K | |
| 4 |
Wells Fargo
San Francisco,
California
|
+$9.84K |
| 5 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$2K |
Top Sellers
| 1 | -$344K | |
| 2 | -$35K | |
| 3 | -$16.1K | |
| 4 |
JAM
JW Asset Management
Miami Beach,
Florida
|
-$14K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$3.77K |